来自:中国糖尿病杂志 编辑:张霞 刘立朝 于蕊 王晓梅 李琳 张晓 |点击数:|2015-01-28
【关键词】糖尿病,2型;投药, 口服;糖化血红蛋白;口服降糖药;血糖控制达标
【Abstract】 Objective To assess the 3-year status of glycaemic control in type 2 diabetic outpatients on oral antidiabetic drugs (OADs) in Dalian. Methods The clinical data of a total of 1171, 1196 and 1245 outpatients with type 2 diabetes (T2DM) inform 2009, 2010 and 2011 respectively, were collected according to questionnaire and clinical blood results. Results The mean hemoglobin A1c (HbA1c) in 2009, 2010 and 2011 was (8.8±2.1)%, (8.5±1.9)% and (8.8±2.3)% respectively. There were 20.6% of informants targeted HbA1c<7%in 2009,21.3% of informants targeted HbA1c<7%in 2010 and 21.6% of informants targeted HbA1c<7%in 2011. For therapeutic protocols,39.0% of patients were undertaking the single OAD treatment, while 50.3% of patients with two kinds of OADs and 10.7% with three kinds OADs or more. It was found that 43.4%, 27.0% and 11.5% of the patients receiving one OAD, two OADs and three OADs or more achieved glycaemic control target. The ordinal ratio of OADs consumption was metformin (M), glucosidase inhibitors (A), sulfonylureas (S), glinides (G) and TZDs (T). Among the combined treatment regimens, M+A was the most frequently used compared with S+M, S+A, G+M, G+A and M+T. Conclusions The target rate of blood glucose control in our survey is less than 25%. Among all OADs, M and A are frequently used in outpatients of T2DM and two OADs combination treatment regimen is most frequently used in all therapeutic protocols. The patients receiving one OAD achieved the best blood glucose control.
【Key words】Type 2 diabetes;Administration, Oral ;Hemoglobin/Hemoglobin (HbA1c);Oral antidiabetic drugs;Glycaemic control target
版权所有:《中国糖尿病杂志》社 主管单位:中华人民共和国教育部 主办单位:北京大学
地址:北京市西城区大红罗厂街1号 邮编:100034 电话(传真):010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持:九度创想